Lombarditis (Pericarditis) – Comprehensive Patient Guide
Overview
Lombarditis is an informal name occasionally used for pericarditis, the inflammation of the thin, double‑layered sac (the pericardium) that surrounds the heart. The condition may be acute (sudden onset, lasting days to weeks) or chronic (lasting months or recurring). Pericarditis can affect anyone, but its incidence peaks in certain age groups and under specific circumstances.
- Incidence: Approx. 27 to 35 cases per 100,000 adults each year in the United States 1. In Europe, the rate is similar, with slightly higher numbers in men.
- Age & gender: Most common in people aged 20‑50 years. Men are 1.5‑2× more likely to develop acute pericarditis than women. > Geography: No major regional differences, though infectious causes (e.g., tuberculosis) are more frequent in low‑income countries.
- Outcomes: The majority (≈80 %) recover completely with simple anti‑inflammatory therapy; however, about 5‑7 % develop complications such as cardiac tamponade or constrictive pericarditis 2.
Symptoms
Symptoms may vary from mild chest discomfort to severe, life‑threatening pain. Below is a complete list with brief explanations.
Chest pain
- Typical character: Sharp or stabbing, worsens when lying flat or inhaling deeply, and eases when sitting up or leaning forward.
- Radiation: May spread to the left shoulder, neck, or back.
Fever & systemic signs
- Low‑grade fever (37.5‑38.5 °C) in up to 60 % of cases; higher fevers suggest an infectious cause.
- General malaise, fatigue, and night sweats.
Dyspnea (shortness of breath)
- Often mild, but can be pronounced if pericardial effusion limits cardiac filling.
Palpitations
- Feeling of a rapid or irregular heartbeat, especially if the inflammation irritates the outer heart layer.
Syncope (fainting)
- Rare; usually indicates a large effusion or tamponade.
Other possible findings
- Swelling of the ankles (if fluid overload develops).
- Weight loss (in chronic or autoimmune‑mediated cases).
- Joint pain or rash (when pericarditis is part of a systemic disease such as lupus).
Causes and Risk Factors
Pericarditis is a “final common pathway” that can be triggered by many different processes.
Infectious agents
- Viral: Coxsackie B, echovirus, adenovirus, influenza, COVID‑19, HIV – the most frequent cause in the U.S. and Europe.
- Bacterial: *Staphylococcus*, *Streptococcus*, *Mycobacterium tuberculosis* (especially in endemic regions).
- Fungal & parasitic: Rare, seen in immunocompromised hosts.
Non‑infectious triggers
- Post‑cardiac injury: After heart surgery, myocardial infarction (Dressler syndrome), pacemaker/lead implantation, trauma.
- Autoimmune / systemic diseases: Systemic lupus erythematosus, rheumatoid arthritis, scleroderma, Sjögren’s syndrome.
- Metabolic: Uremia (advanced kidney failure), hypothyroidism.
- Neoplastic: Direct involvement by lung, breast, or lymphoma cancers.
- Medications & radiation: Certain drugs (e.g., procainamide, hydralazine) and chest radiation.
Risk factors
- Recent viral illness or upper respiratory infection.
- Recent cardiac surgery or invasive cardiac procedures.
- Autoimmune disease history.
- Chronic kidney disease on dialysis.
- Immunosuppression (HIV, transplant, chemotherapy).
- Male gender and age 20‑50 for idiopathic/viral cases.
Diagnosis
Diagnosis is based on a combination of clinical presentation, physical examination, and targeted investigations.
History and Physical Exam
- Typical chest pain pattern and positional relief.
- Friction rub heard over the left lower sternal border – a high‑yield bedside sign.
- Assessment for fever, recent infections, and systemic disease clues.
Electrocardiogram (ECG)
Seen in >90 % of acute cases:
- Diffuse ST‑segment elevation in multiple leads (not limited to a coronary artery distribution).
- PR‑segment depression in most leads (helps differentiate from myocardial infarction).
- ECG may normalize within weeks; persistent changes warrant further evaluation.
Chest X‑ray
- May be normal.
- Can show an enlarged cardiac silhouette if a large pericardial effusion is present.
Echocardiography (Echo)
First‑line imaging to assess fluid amount, ventricular motion, and signs of tamponade. Sensitivity >95 % for clinically significant effusions.
Blood Tests
- Complete blood count (CBC) – may show leukocytosis.
- Inflammatory markers: C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) – usually elevated.
- Cardiac enzymes (troponin) – modest rise in up to 30 % due to epicardial irritation, but not to the levels seen in MI.
- Serologies for viral causes, autoimmune panels (ANA, RF), and renal function tests when indicated.
Advanced Imaging (if needed)
- Cardiac MRI – excellent for tissue characterization, detecting pericardial thickening or inflammation.
- CT scan – useful for evaluating calcification or masses.
Treatment Options
Treatment goals are to relieve pain, control inflammation, prevent recurrence, and address the underlying cause.
First‑line medical therapy
- Non‑steroidal anti‑inflammatory drugs (NSAIDs): Ibuprofen 600‑800 mg every 6–8 h or Aspirin 750‑1000 mg every 6 h for 1‑2 weeks, then taper. NSAIDs reduce pain and inflammation quickly.
- Colchicine: 0.5‑0.6 mg twice daily for 3 months (or 0.6 mg daily if weight < 70 kg). Proven to lower recurrence risk by >50 % (ICHD‑3 guidelines) 3.
- Corticosteroids: Prednisone 0.2‑0.5 mg/kg/day for patients who cannot tolerate NSAIDs/colchicine or have autoimmune pericarditis. Use the lowest effective dose and taper over 4‑6 weeks to avoid recurrence.
Targeted therapy for specific causes
- Antibiotics for bacterial pericarditis (e.g., ceftriaxone + vancomycin pending cultures).
- Anti‑tubercular regimen (RIPE therapy) for tuberculous pericarditis.
- Anti‑viral treatment (e.g., acyclovir) only in rare cases with proven HSV/CMV infection.
- Immunosuppressants (azathioprine, methotrexate) for refractory autoimmune pericarditis.
Procedural interventions
- Pericardiocentesis: Needle drainage of a large or symptomatic effusion, especially if tamponade physiology is present.
- Surgical pericardial window or pericardiectomy: Considered for recurrent effusions, constrictive pericarditis, or when malignancy is suspected.
Lifestyle & supportive measures
- Rest for the first few days; avoid strenuous activity until pain resolves and inflammation markers normalize.
- Stay hydrated; limit alcohol and caffeine which may exacerbate tachycardia.
- Gradual return to exercise (typically 2‑4 weeks) under physician guidance.
Living with Lombarditis (pericarditis)
Most patients return to normal life within weeks, but ongoing self‑care helps prevent relapse.
- Medication adherence: Finish the full colchicine course even after symptoms improve.
- Follow‑up appointments: Repeat ECG and echo 1‑2 weeks after discharge, then at 3‑month intervals if you had a large effusion.
- Monitor symptoms: Keep a diary of chest pain, fever, or breathlessness and report new changes promptly.
- Vaccinations: Stay up‑to‑date with influenza and COVID‑19 vaccines, which lower the risk of viral triggers.
- Stress management: Chronic stress may aggravate autoimmune activity; consider mindfulness, yoga, or counseling.
Prevention
While not all cases are preventable, several strategies reduce risk.
- Prompt treatment of upper respiratory infections and influenza; consider antiviral therapy for high‑risk patients.
- Good oral hygiene and dental care to limit bacterial seeding.
- Manage chronic diseases—control hypertension, diabetes, and especially kidney disease (dialysis adequacy).
- Avoid excessive alcohol and illicit drug use that can precipitate myocarditis/pericarditis.
- For patients on certain medications (e.g., hydralazine, procainamide), discuss alternative agents with your doctor.
Complications
Most cases resolve without sequelae, but untreated or severe pericarditis can lead to serious outcomes.
- Cardiac tamponade: Accumulation of fluid compresses the heart, causing hypotension and shock. Requires urgent pericardiocentesis.
- Constrictive pericarditis: Thickened, scarred pericardium restricts diastolic filling; may need surgical pericardiectomy.
- Recurrent pericarditis: Occurs in 15‑30 % of patients, often after early NSAID discontinuation or steroid taper.
- Chronic heart failure: Result of prolonged inflammation or constriction.
- Mortality: Overall 1‑2 % 30‑day mortality in developed countries; higher (≈10 %) in tuberculous or malignant pericarditis 2.
When to Seek Emergency Care
- Sudden, severe chest pain that does not improve when sitting up or worsens rapidly.
- Shortness of breath at rest or feeling that you cannot get a full breath.
- Fainting, feeling light‑headed, or a rapid drop in blood pressure (pulse < 60 bpm with low BP).
- Rapid heartbeat (>120 bpm) accompanied by dizziness.
- Swelling of the neck veins (jugular venous distention) or a feeling of fullness in the neck.
- Sudden worsening of symptoms after a recent chest injury or cardiac procedure.
These signs may indicate cardiac tamponade or a life‑threatening complication that requires immediate intervention.
References:
- Mayo Clinic. Pericarditis. https://www.mayoclinic.org (accessed June 2026).
- American Heart Association. Pericardial Disease Statistics. https://www.heart.org (2024).
- International Society for Pericardial Diseases. 2022 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. ESC Guidelines.
- Cleveland Clinic. Pericarditis Treatment & Management. https://my.clevelandclinic.org (2023).
- World Health Organization. Tuberculosis and the Heart. WHO Fact Sheets (2022).